» Articles » PMID: 6690997

The Establishment and Maintenance of Pregnancy Using in Vitro Fertilization and Embryo Donation in a Patient with Primary Ovarian Failure

Overview
Journal Nature
Specialty Science
Date 1984 Jan 12
PMID 6690997
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

Ovarian steroid replacement therapy in the ovariectomized ewe, given in the correct sequence to mimic endogenous steroid changes in the normal ovulatory cycle, allows the development of embryos transferred in utero. A similar type of sequential therapy was designed for steroid replacement in women with primary ovarian failure. This produces the histological changes in uterine endometrial morphology and plasma oestradiol and progesterone similar to those observed in the normal ovulatory cycle. We now report that in one of these women a donated oocyte, fertilized by her husband's spermatozoa and cultured to the two-cell stage in vitro, was transferred in utero, resulting in a normal pregnancy and the delivery of a healthy child. Oestrogen therapy was withdrawn at 12 weeks and progesterone at 19 weeks gestation. This technique allows the treatment of human infertility due to primary ovarian failure.

Citing Articles

Efficacy of modified natural cycle vs. hormone replacement therapy in oocyte donation for recipients of advanced maternal age: a retrospective study.

Gavilan C, Castillo J, Ortiz J, Morraja J, Quetglas C, Bernabeu A J Assist Reprod Genet. 2024; 42(2):433-439.

PMID: 39739213 PMC: 11871195. DOI: 10.1007/s10815-024-03376-3.


Oocyte donors' experience and expectations in a non-profit fertility care setting.

Li Piani L, Tshilembi A, De Vos M, Buyse E, Ruttens S, Somigliana E J Assist Reprod Genet. 2024; 41(9):2337-2347.

PMID: 39042340 PMC: 11405610. DOI: 10.1007/s10815-024-03203-9.


Development of the DONOR prediction model on the risk of hypertensive complications in oocyte donation pregnancy: study protocol for a multicentre cohort study in the Netherlands.

Lafeber G, Van der Endt V, Louwers Y, le Cessie S, van der Hoorn M, Lashley E BMJ Open. 2024; 14(7):e079394.

PMID: 38960461 PMC: 11227773. DOI: 10.1136/bmjopen-2023-079394.


Reflections on appropriately liberalizing ART for groups requiring special attention in China.

Dong X, Sun W, Du P, Xiao Q, Ren H J Assist Reprod Genet. 2024; 41(7):1755-1761.

PMID: 38958870 PMC: 11263302. DOI: 10.1007/s10815-024-03184-9.


Prioritising and incentivising productivity within indicator-based approaches to Research Impact Assessment: a commentary.

Deeming S, Hure A, Attia J, Nilsson M, Searles A Health Res Policy Syst. 2023; 21(1):136.

PMID: 38110938 PMC: 10726490. DOI: 10.1186/s12961-023-01082-7.